News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

GlaxoSmithKline (GSK) Plugs Into Bioelectronics With $50 Million Venture Fund



8/8/2013 7:15:50 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

GlaxoSmithKline raised its bet on using electrical signals in the body to target diseases on Thursday with the launch of a $50 million strategic venture capital fund. Britain's biggest drugmaker hopes to have the first medicine that effectively speaks the electrical "language" of the body ready for approval by the end of this decade. GSK said the new fund's first investment would be in SetPoint Medical, a California company working on implantable devices to treat inflammatory diseases.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Bloomberg
Read at Wired
Read at Gulf News


comments powered by Disqus
Reuters
Bloomberg
Wired
Gulf News
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES